10x Genomics CEO Disposes $122,784 in Stock as Shares Hover Near 52-Week High
10x Genomics Chief Executive Officer Serge Saxonov sold 5,000 shares of Class A common stock on April 14, 2026, for $122,784 under a previously established Rule 10b5-1 plan. The sale occurred while the stock traded close to its 52-week high, amid a backdrop of upbeat operational updates, an analyst upgrade, institutional selling and valuation conce…